Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Leukemia

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2009.161PMID 19657361
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FOXP3 positive regulatory T‐cells in cutaneous and systemic CD30 positive T‐cell lymphoproliferations

  2008cited by this paper
• Insulin-like growth factor binding protein 7 mediates glioma cell growth and migration.

  2008cited by this paper
• Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

  2008cited by this paper
• Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

  2008cited by this paper
• Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma

  2007cited by this paper
• Anaplastic Large Cell Lymphoma.

  2007cited by this paper
• Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes.

  2007cited by this paper
• The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.

  2007cited by this paper
• Pathobiology of ALK+ anaplastic large-cell lymphoma.

  2007cited by this paper
• Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

  2006cited by this paper
• Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

  2006cited by this paper
• Polycomb silencers control cell fate, development and cancer

  2006cited by this paper
• Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.

  2005cited by this paper
• Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas

  2005cited by this paper
• High expression of calcium‐binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma

  2005cited by this paper
• Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas

  2005cited by this paper
• Mechanisms of B-cell lymphoma pathogenesis

  2005cited by this paper
• Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.

  2005cited by this paper
• Gene Expression Profiling in Anaplastic Large Cell Lymphoma and Hodgkin's Disease

  2004cited by this paper
• Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma

  2004cited by this paper
• Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.

  2004cited by this paper
• Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.

  2004cited by this paper
• The Biology of the Ets1 Proto-Oncogene

  2003cited by this paper
• ALK‐negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects–a review

  2003cited by this paper
• CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.

  2003cited by this paper
• Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2003cited by this paper
• Isolation of differentially expressed genes in NPM‐ALK‐positive anaplastic large cell lymphoma

  2002cited by this paper
• cDNA arrays: Gene expression profiles of Hodgkin's disease and anaplastic large cell lymphoma cell lines

  2002cited by this paper
• T Cell-specific Expression of the MurineCD3δ Promoter*

  2002cited by this paper
• T cell-specific expression of the murine CD3delta promoter.

  2002cited by this paper
• Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

  2002cited by this paper
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

  2001cited by this paper
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB

  2001cited by this paper
• Distinct BMI-1 and EZH2 Expression Patterns in Thymocytes and Mature T Cells Suggest a Role for Polycomb Genes in Human T Cell Differentiation

  2001cited by this paper
• Anaplastic Large Cell Lymphoma: The Shifting Sands of Diagnostic Hematopathology

  2001cited by this paper
• Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.

  2000cited by this paper
• Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein1 2

  2000cited by this paper
• CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

  2000cited by this paper
• Transcriptional regulation of T lymphocyte development and function.

  1999cited by this paper
• Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.

  1997cited by this paper
• Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.

  1996cited by this paper
• High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.

  1996cited by this paper
• Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins.

  1993cited by this paper
• Large cell lymphoma.

  1989cited by this paper
• The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

  1985cited by this paper
• Nuclear Factor (cid:2) B–dependent Gene Expression Profiling of Hodgkin’s Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity

  year unknowncited by this paper

• GANT61 suppresses proliferation and induces apoptosis in ALK-Positive anaplastic large cell lymphoma via modulating the Hh-PIK3IP1-Akt signaling axis

  2026cites this paper
• HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy

  2025cites this paper
• Systemic ALK-Negative Anaplastic Large Cell Lymphoma: Insights into Morphologic, Immunophenotypic, Genetic and Molecular Characteristics.

  2024cites this paper
• Current views on the etiology and pathogenesis of ALK-positive anaplastic large cell lymphoma

  2024cites this paper
• Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment

  2024cites this paper
• [ALK-positive anaplastic large cell lymphoma of paranasal sinuses: two cases report and literature review].

  2024cites this paper
• Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability

  2023cites this paper
• Amino acid metabolism in health and disease

  2023cites this paper
• Differential molecular programs of cutaneous anaplastic large cell lymphoma and CD30-positive transformed mycosis fungoides

  2023influential citation
• The emerging role of the branched chain aminotransferases, BCATc and BCATm, for anti-tumor T-cell immunity

  2023cites this paper
• NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma

  2023cites this paper
• Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis

  2022cites this paper
• Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas

  2022cites this paper
• The expression and biological effect of NR2F6 in non-small cell lung cancer

  2022cites this paper
• Transcriptional coregulator Ess2 controls survival of post-thymic CD4+ T cells through the Myc and IL-7 signaling pathways

  2022cites this paper
• BDP1 Expression Correlates with Clinical Outcomes in Activated B-Cell Diffuse Large B-Cell Lymphoma

  2022cites this paper
• Tissue Expander–associated T Cells: Relevance to Breast Implant–associated Anaplastic Large-cell Lymphoma

  2022cites this paper
• Diffuse large B-Cell lymphoma: from novel molecular classifications to tailored targeted therapies

  2022cites this paper
• Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma

  2021cites this paper
• CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

  2021cites this paper
• Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6

  2021cites this paper
• Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)

  2021cites this paper
• Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy.

  2021cites this paper
• Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas

  2021cites this paper
• Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma

  2021cites this paper
• ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies

  2021influential citation
• Regulation of NKG2D by RKIP: Implications on NK-mediated cytotoxicity and cytokine production

  2021cites this paper
• Usefulness of BATF3 Immunohistochemistry in Diagnosing Classical Hodgkin Lymphoma

  2021cites this paper
• Function of Deptor and its roles in hematological malignancies

  2021cites this paper
• The Spectrum of Anaplastic Large‐cell Lymphoma

  2021cites this paper
• Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma

  2021cites this paper
• The GIMAP Family Proteins: An Incomplete Puzzle

  2021cites this paper
• Pathology and Molecular Pathology of Hodgkin Lymphoma

  2020cites this paper
• IL10RA Modulates Crizotinib Sensitivity in NPM1-ALK-positive Anaplastic Large Cell Lymphoma.

  2020cites this paper
• Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma

  2020influential citation
• A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma

  2020cites this paper
• Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target

  2020cites this paper
• Response to Gagat et al.

  2019cites this paper
• The Pathogenesis of Anaplastic Large Cell Lymphoma

  2019cites this paper
• Integration of Transcriptional and Mutational Data improves the Stratification of 1 Peripheral T-Cell Lymphoma 2

  2019cites this paper
• From bench to bedside: the past, present and future of therapy for systemic paediatric ALCL, ALK+

  2019cites this paper
• SURF4 has oncogenic potential in NIH3T3 cells.

  2018cites this paper
• PATRI, a Genomics Data Integration Tool for Biomarker Discovery

  2018cites this paper
• Emerging EZH2 Inhibitors and Their Application in Lymphoma

  2018cites this paper
• The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

  2018cites this paper
• Are lymphomas result of aberrant epigenentic regulation of immune system? molecular insights and therapeutic prospects

  2018cites this paper
• Composite Lymphomas and the Relationship of Hodgkin Lymphoma to Non-Hodgkin Lymphomas

  2018cites this paper
• The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

  2018cites this paper
• Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

  2018cites this paper
• Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model

  2018influential citation
• Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade

  2018cites this paper
• SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile.

  2018cites this paper
• An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma

  2018cites this paper
• Crizotinib induces apoptosis and gene expression changes in ALK+ anaplastic large cell lymphoma cell lines; brentuximab synergizes and doxorubicin antagonizes

  2018cites this paper
• Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells

  2018cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• Inflammatory macrophage-associated 3-gene signature predicts subclinical allograft injury and graft survival.

  2018cites this paper
• Hodgkin’s lymphoma and its association with EBV and HIV infection

  2018cites this paper
• Hyperpolarization-activated cyclic nucleotide-gated gene signatures and poor clinical outcome of cancer patient

  2017cites this paper
• Cancer-type dependent expression of CK2 transcripts

  2017cites this paper
• An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive

  2017cites this paper
• SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis

  2017cites this paper
• Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment.

  2017cites this paper
• The heterogeneous landscape of ALK negative ALCL

  2017cites this paper
• NPM-ALK expression levels identify two distinct subtypes of paediatric anaplastic large cell lymphoma

  2017cites this paper
• Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling

  2016influential citation
• Challenging perspectives on the cellular origins of lymphoma

  2016cites this paper
• Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

  2016cites this paper
• Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma

  2016cites this paper
• Survival of mature T cells in the periphery is intrinsically dependent on GIMAP1 in mice

  2016cites this paper
• Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.

  2016cites this paper
• SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.

  2016cites this paper
• Thermoresponsive Collagen/Cell Penetrating Hybrid Peptide as Nanocarrier in Targeting-Free Cell Selection and Uptake.

  2016cites this paper
• Genetics of anaplastic large cell lymphoma

  2016cites this paper
• NIAM, a novel activator of p53 and potential tumor suppressor

  2015cites this paper
• Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

  2015cites this paper
• Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis

  2015cites this paper
• Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation

  2015cites this paper
• The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance

  2015cites this paper
• Principles in the design of ligand-targeted cancer therapeutics and imaging agents

  2015cites this paper
• The role of AP-1 and epigenetics in ALCL.

  2015cites this paper
• A comprehensive time-course–based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set

  2015cites this paper
• The origins of ALK translocations.

  2015cites this paper
• Identi fi cation of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB 4 transcripts

  2015cites this paper
• Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

  2015cites this paper
• Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer

  2015cites this paper
• SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.

  2014cites this paper
• Hodgkin Lymphoma: Pathology, Pathogenesis, and a Plethora of Potential Prognostic Predictors

  2014cites this paper
• Biomarker development for pancreatic ductal adenocarcinoma using integrated analysis of mRNA and miRNA expression

  2014cites this paper
• Unexpected Phenotype of Mice Lacking Shcbp1, a Protein Induced during T Cell Proliferation

  2014cites this paper
• Study of the diagnostic utility of fascin and PU.1 in Hodgkin’s lymphoma, diffuse large B-cell lymphoma, and anaplastic large cell lymphoma

  2014cites this paper
• NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas

  2014cites this paper
• A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma

  2014cites this paper
• LYMPHOID NEOPLASIA SATB 1 overexpression promotes malignant T-cell proliferation in cutaneous CD 30 1 lymphoproliferative disease by repressing p 21

  2014cites this paper
• Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway

  2014cites this paper
• Orphan nuclear receptor NR2F6 acts as an essential gatekeeper of Th17 CD4+ T cell effector functions

  2014cites this paper
• Increased Expression of Phosphorylated FADD in Anaplastic Large Cell and Other T-Cell Lymphomas

  2014cites this paper
• A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation

  2014cites this paper
• Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy

  2014cites this paper
• Cancer Genomics

  2013cites this paper